Remibrutinib
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: Remibrutinib inhibits BTK activity with an IC50 value of 0.023 µM in blood.... more
Product information "Remibrutinib"
Description: Remibrutinib inhibits BTK activity with an IC50 value of 0.023 µM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1 nM). Remibrutinib has the potential for Chronic urticaria (CU) treatment. Target: BTK. Smiles: CN(CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(cc2F)C2CC2)c1C)C(=O)C=C. References: Daniela Angst, et al. Novel amino pyrimidine derivatives. Patent WO2015079417A1.
| Supplier: | TargetMol |
| Supplier-Nr: | T16730 |
Properties
| Application: | Targets Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2] (BTK) |
| MW: | 507.53 D |
| Formula: | C27H27F2N5O3 |
Database Information
| CAS : | 1787294-07-8| Matching products |
| KEGG ID : | K07370 | Matching products |
Handling & Safety
| Storage: | +4°C |
| Shipping: | +4°C (International: +4°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H317, H334 |
| P Phrases: | P261, P272, P280, P284, P321, P302+P352, P304+P341, P333+P313, P342+P311, P362+P364, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed